In-hospital de prescribing in the real world – a clinician-led approach to hyper poly pharmacy

Authors

  • Pulicherla Manju Bhargavi Pharmaceutics Dr.K.V. Subba Reddy Institute of Pharmacy (Approved by AICTE,P.C.l New Delhi& Permanently Affiliated to JNTUA Anantapuramu MOU with Government General Hospital &KMC, K urnool. Author
  • M. Vasavi Pharmaceutics Dr.K.V. Subba Reddy Institute of Pharmacy (Approved by AICTE,P.C.l New Delhi& Permanently Affiliated to JNTUA Anantapuramu MOU with Government General Hospital &KMC, K urnool. Author
  • Dr. B. V. Ramana Pharmaceutics Dr.K.V. Subba Reddy Institute of Pharmacy (Approved by AICTE,P.C.l New Delhi& Permanently Affiliated to JNTUA Anantapuramu MOU with Government General Hospital &KMC, K urnool. Author

DOI:

https://doi.org/10.62649/

Keywords:

Deprescribing, Hyperpolypharmacy, Polypharmacy, Acute Medical Ward, and Clinician-Led.

Abstract

Insufficient information on how to safely stop taking many medications has aided in the spread of polypharmacy. The chance to begin deprescribing is particularly useful during hospitalization. Pharmacists or multidisciplinary teams often lead deprescribing efforts, which are generally well-received by patients and have little risks. However, only a small number of research have looked into therapies that can really be used by doctors in the clinic. The study's goal is to determine whether or not a deprescribing initiative guided by clinicians can be successfully implemented on an acute general medicine ward. Procedures Patients with hyperpolypharmacy (> 10 drugs) were subjected to a comprehensive intervention including (a) deprescribing education sessions and (b) a deprescribing alert in their bedside files. We used a historical cohort research design to compare the intervention cohort's data to those of a control group from the past. After the intervention was over, a sample of the group was queried to gauge sentiments about describing. Conclusions Out of a total of 1333 patients enrolled, 1169 had full data sets analyzed (nintervention = 888, ncontrol = 281). Despite a drop in the prevalence of hyperpolyphar- macy from 28% to 26% in the intervention group, this difference was not statistically significant (net change = —1, IQR = —2-0; p = 0.26). Furthermore, the intervention did not lead to a statistically significant increase or decrease in medication use among any of the other categories. Many people who were interviewed about deprescribing agreed that they were taking too many drugs.  In conclusion, we showed that it is possible to implement clinician-led deprescribing programs even in resource-poor, high-volume inpatient units, despite not finding a statistically significant impact of the intervention. Further research in large inpatient cohorts is needed to examine the long-term patient outcomes and harmful effects of medications after simple, creative deprescribing methods in hospitals.

Downloads

Published

2021-10-15

How to Cite

In-hospital de prescribing in the real world – a clinician-led approach to hyper poly pharmacy. (2021). Indo-American Journal of Agricultural and Veterinary Sciences, 9(4), 43-50. https://doi.org/10.62649/

Similar Articles

11-14 of 14

You may also start an advanced similarity search for this article.